Skip to main content
infokogum
ET

21101Manufacture of basic pharmaceutical products  

15 companies

CompaniesRanking

This activity has special requirements (e.g. a licence or notice).

Largest companies by revenue

  1. 1.Acino Estonia OÜ
    14072902, Põlva linn
    Revenue 2025
    €32.7M
    +24%
    Net profit
    €1.6M
    +48%
    Employees
    117
  2. 2.osaühing TBD Pharmatech
    11204964, Tartu linn
    Revenue 2025
    €5.1M
    −19%
    Net profit
    €499.6K
    −66%
    Employees
    62
  3. 3.Nordaid OÜ
    12082150, Haabersti linnaosa
    Revenue 2025
    €980.8K
    +0.3%
    Net profit
    €200K
    +212%
    Employees
    7
  4. 4.PharmaSynth AS
    11044101, Tartu linn
    Revenue 2025
    €896.3K
    +53%
    Net profit
    €236.1K
    +55%
    Employees
    9
  5. 5.osaühing REVELIKO
    10010560, Tartu linn
    Revenue 2025
    €51.8K
    +42%
    Net profit
    €17.2K
    +543%
    Employees
    1
  6. 6.Bestafter OÜ
    14962240, Kesklinna linnaosa
    Revenue 2025
    €100
    −50%
    Net profit
    €47
    +27%
    Employees
    0

Includes

This class includes: - manufacture of active pharmaceutical ingredients to be used for their pharmacological properties in the manufacture of medical products (e.g. antibiotics, basic vitamins, salicylic and O-acetylsalicylic acids) - processing of blood This class also includes: - manufacture of chemically pure sugars - manufacture of probiotics - processing of glands and manufacture of extracts of glands, etc.

Also includes

glycosides, vegetable alkaloids and their derivatives lysine and its esters and salts, glutamic acid its salts

Excludes

manufacture of advanced cell and gene therapy pharmaceutical preparations, see 21201